Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Correction: Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels (Neuropsychopharmacology, (2019), 44, 7, (1328-1334), 10.1038/s41386-019-0324-9)

Research output: Contribution to journalComment/debateResearchpeer-review

  1. Dopaminergic drugs in the treatment of depression

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Hot and cold cognitive disturbances in antidepressant-free patients with major depressive disorder: a NeuroPharm study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Structural brain abnormalities associated with cognitive impairments in bipolar disorder

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. NeuroPharm study: EEG wakefulness regulation as a biomarker in MDD

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

The original version of this article contained an error in the labelling of Figures 2 and 3. While the captions and figures themselves are correct, in order to correspond with the in-text references, they have now been re-numbered in both the PDF and HTML versions of the article.

Original languageEnglish
JournalNeuropsychopharmacology
Volume44
Issue number7
Pages (from-to)1336-1337
Number of pages2
ISSN0893-133X
DOIs
Publication statusPublished - 1 Jun 2019

ID: 57812386